PMID

Data

Article Title

Organization

Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARa Selective Agonist.

Bristol-Myers Squibb Co.

Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR)ß Agonist.

Vitae Pharmaceuticals Inc

Discovery of Second Generation ROR? Inhibitors Composed of an Azole Scaffold.

Kyoto Prefectural University of Medicine

Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN).

Arizona State University

Discovery of potent and selective PPAR?/? dual antagonists and initial biological studies.

Inception Sciences

Structure-activity relationship study on benzoic acid part of diphenylamine-based retinoids.

Tohoku Pharmaceutical University